TrialHematological oncology2020

Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.

Stefan Hatzl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.